MARKET OUTLOOK
Triton Market Research, in its report on the market for continuous glucose monitoring system comprising (CGMS) and self-monitoring of blood glucose (SMBG) in the United Kingdom, estimates it to proliferate with a compound annual growth rate of 33.45% and 5.82% respectively, in the forecast years between 2019 and 2025.
Studies conducted among the people in the UK have reported approximately 3.7 million people of the country’s population suffering from diabetes. The United Kingdom, being one of the developed nations in the world, has advanced medical facilities and lucrative policies for reimbursement. Thus, the increasing prevalence of diabetes, along with favorable reimbursement policies, act as drivers propelling the growth of the glucose monitoring system market in the United Kingdom. Measuring blood glucose levels is a painful process, as it requires pricking oneself with a needle. This makes a patient averse to using devices that cause such injuries, which acts as a major limiting factor to the growth of the glucose monitoring system market.
COMPETITIVE OUTLOOK
The renowned companies in the United Kingdom glucose monitoring system market are Johnson & Johnson, i-SENS, Inc., Abbott, Nemaura Medical, Inc., Ypsomed, Dexcom, Ascensia, Roche Diagnostics, B Braun Melsungen AG, Becton Dickinson and Company and Medtronic.